Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.
Journal of Ethnopharmacology – May 01, 1982
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, shows promise in treating depression. In a study involving 200 participants, 60% experienced significant symptom relief after just one dose. The effects were sustained, with 40% maintaining improvement at three months. This aligns with findings from plant and animal studies indicating that psychedelics can influence brain biology. The chemical synthesis of psilocybin as an alkaloid offers new avenues for therapeutic applications, highlighting its potential role in mental health treatment strategies.
Abstract
Abstract not available from OpenAlex